Compare SVRE & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRE | ISPC |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | Israel | United States |
| Employees | 35 | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.8M |
| IPO Year | N/A | 2020 |
| Metric | SVRE | ISPC |
|---|---|---|
| Price | $4.46 | $3.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.8K | ★ 192.3K |
| Earning Date | 05-12-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | $1,793.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $0.10 |
| 52 Week High | $6.30 | $6.77 |
| Indicator | SVRE | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 45.43 |
| Support Level | $1.30 | $0.33 |
| Resistance Level | $4.92 | $4.49 |
| Average True Range (ATR) | 0.39 | 0.34 |
| MACD | -0.08 | -0.18 |
| Stochastic Oscillator | 39.13 | 4.53 |
Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.